Status:
COMPLETED
ICBT for Pain-predominant FGIDs in Children and Adolescents: an Implementation Study.
Lead Sponsor:
Karolinska Institutet
Conditions:
Functional Gastrointestinal Disorders
Irritable Bowel Syndrome
Eligibility:
All Genders
8-17 years
Phase:
NA
Brief Summary
This open trial aims to evaluate feasibility and preliminary effectiveness of an internet-delivered CBT-program for children and adolescents with functional gastrointestinal disorders when implemented...
Detailed Description
Pain predominant functional gastrointestinal disorders (P-FGIDs) are common in children and adolescents and associated with impaired quality of life. Our research group have previously in a series of ...
Eligibility Criteria
Inclusion
- Age 8-17 at date of inclusion.
- Fulfilling Rome IV-criteria for irritable bowel syndrome, functional dyspepsia or functional abdominal pain with a written statement from patient's physician confirming a diagnosis.
- Stable psychotropic medication for at least 1 month.
Exclusion
- concurrent serious medical conditions.
- a psychiatric diagnosis, judged to be a more important treatment target than the abdominal pain.
- on-going structured psychological treatment.
- absence from school exceeding an average of 2 days a week the last month is a cause for exclusion since high school absence demands more intensive interventions than can be offered in ICBT.
- on-going abuse or severe parental psychiatric illness in the family.
- since treatment format assumes normal reading and writing skills, pronounced language skill deficits and learning difficulties lead to exclusion from the study.
- lack of regular internet-access.
Key Trial Info
Start Date :
September 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 18 2018
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT03252743
Start Date
September 1 2017
End Date
December 18 2018
Last Update
February 26 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Clinical Neuroscience, Karolinska Institutet
Stockholm, Sweden